A citation-based method for searching scientific literature

F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder, M F Avril, E Azizi, P van Belle, W Bergman, G Bianchi-Scarrà, B Bressac-de Paillerets, D Calista, C Carrera, J Hansson, M Harland, D Hogg, V Höiom, E A Holland, C Ingvar, M T Landi, J M Lang, R M Mackie, G J Mann, M E Ming, C J Njauw, H Olsson, J Palmer, L Pastorino, S Puig, J Randerson-Moor, M Stark, H Tsao, M A Tucker, P van der Velden, X R Yang, N Gruis. J Natl Cancer Inst 2010
Times Cited: 76







List of co-cited articles
833 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
260
34

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
339
32

MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
Sara Raimondi, Francesco Sera, Sara Gandini, Simona Iodice, Saverio Caini, Patrick Maisonneuve, Maria Concetta Fargnoli. Int J Cancer 2008
233
26

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
280
25

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
283
22

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
22

Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
C Kennedy, J ter Huurne, M Berkhout, N Gruis, M Bastiaens, W Bergman, R Willemze, J N Bavinck. J Invest Dermatol 2001
295
21

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
19


MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
N F Box, D L Duffy, W Chen, M Stark, N G Martin, R A Sturm, N K Hayward. Am J Hum Genet 2001
220
18

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Peter A Kanetsky, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming, Lynn Schuchter, Timothy R Rebbeck. Cancer 2010
74
18

MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Maria Teresa Landi, Peter A Kanetsky, Shirley Tsang, Bert Gold, David Munroe, Timothy Rebbeck, Jennifer Swoyer, Monica Ter-Minassian, Mohammad Hedayati, Lawrence Grossman,[...]. J Natl Cancer Inst 2005
134
18

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
613
17

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
J S Palmer, D L Duffy, N F Box, J F Aitken, L E O'Gorman, A C Green, N K Hayward, N G Martin, R A Sturm. Am J Hum Genet 2000
386
17

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Maria Concetta Fargnoli, Sara Gandini, Ketty Peris, Patrick Maisonneuve, Sara Raimondi. Eur J Cancer 2010
58
20

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
109
15

Genome-wide association study identifies three loci associated with melanoma risk.
D Timothy Bishop, Florence Demenais, Mark M Iles, Mark Harland, John C Taylor, Eve Corda, Juliette Randerson-Moor, Joanne F Aitken, Marie-Francoise Avril, Esther Azizi,[...]. Nat Genet 2009
335
14

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
444
14

Comprehensive evaluation of allele frequency differences of MC1R variants across populations.
Meg R Gerstenblith, Alisa M Goldstein, Maria Concetta Fargnoli, Ketty Peris, Maria Teresa Landi. Hum Mutat 2007
118
14

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Devarati Mitra, Xi Luo, Ann Morgan, Jin Wang, Mai P Hoang, Jennifer Lo, Candace R Guerrero, Jochen K Lennerz, Martin C Mihm, Jennifer A Wargo,[...]. Nature 2012
278
14

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
50
22

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
83
14

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. J Natl Cancer Inst 2005
146
13

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Damiano Abeni, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
492
13

Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Alisa M Goldstein, Valerie Chaudru, Paola Ghiorzo, Celia Badenas, Josep Malvehy, Lorenza Pastorino, Karine Laud, Benjamin Hulley, Marie-Francoise Avril, Joan A Puig-Butille,[...]. Int J Cancer 2007
40
25

Melanocortin-1 receptor structure and functional regulation.
José C García-Borrón, Berta L Sánchez-Laorden, Celia Jiménez-Cervantes. Pigment Cell Res 2005
239
13

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
118
13

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
118
13

MC1R germline variants confer risk for BRAF-mutant melanoma.
Maria Teresa Landi, Jürgen Bauer, Ruth M Pfeiffer, David E Elder, Benjamin Hulley, Paola Minghetti, Donato Calista, Peter A Kanetsky, Daniel Pinkel, Boris C Bastian. Science 2006
238
11

Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Valérie Chaudru, Karine Laud, Marie-Françoise Avril, Annie Minière, Agnès Chompret, Brigitte Bressac-de Paillerets, Florence Demenais. Cancer Epidemiol Biomarkers Prev 2005
52
17

Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.
P A van der Velden, L A Sandkuijl, W Bergman, S Pavel, L van Mourik, R R Frants, N A Gruis. Am J Hum Genet 2001
134
11

Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Alisa M Goldstein, Maria Teresa Landi, Shirley Tsang, Mary C Fraser, David J Munroe, Margaret A Tucker. Cancer Epidemiol Biomarkers Prev 2005
80
11

Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.
N F Box, J R Wyeth, L E O'Gorman, N G Martin, R A Sturm. Hum Mol Genet 1997
262
11

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
J A Bishop, R C Wachsmuth, M Harland, V Bataille, E Pinney, P MacK, L Baglietto, J Cuzick, D T Bishop. J Invest Dermatol 2000
85
11


Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
488
11

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
11

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
N A Gruis, P A van der Velden, L A Sandkuijl, D E Prins, J Weaver-Feldhaus, A Kamb, W Bergman, R R Frants. Nat Genet 1995
277
11

Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Mario Falchi, Veronique Bataille, Nicholas K Hayward, David L Duffy, Julia A Newton Bishop, Tomi Pastinen, Alessandra Cervino, Zhen Z Zhao, Panos Deloukas, Nicole Soranzo,[...]. Nat Genet 2009
166
10

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
Daniel F Gudbjartsson, Patrick Sulem, Simon N Stacey, Alisa M Goldstein, Thorunn Rafnar, Bardur Sigurgeirsson, Kristrun R Benediktsdottir, Kristin Thorisdottir, Rafn Ragnarsson, Steinunn G Sveinsdottir,[...]. Nat Genet 2008
237
10

Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
David L Duffy, Neil F Box, Wei Chen, James S Palmer, Grant W Montgomery, Michael R James, Nicholas K Hayward, Nicholas G Martin, Richard A Sturm. Hum Mol Genet 2004
195
10

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Orietta Picconi, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
751
10

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
10

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
P Ghiorzo, L Pastorino, P Queirolo, W Bruno, M G Tibiletti, S Nasti, V Andreotti, B Bressac-de Paillerets, G Bianchi Scarrà. Pigment Cell Melanoma Res 2013
65
12

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
10

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Miriam Potrony, Joan Anton Puig-Butillé, Paula Aguilera, Celia Badenas, Cristina Carrera, Josep Malvehy, Susana Puig. J Am Acad Dermatol 2014
36
22

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
203
10

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
224
10

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
9

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Levi A Garraway, Hans R Widlund, Mark A Rubin, Gad Getz, Aaron J Berger, Sridhar Ramaswamy, Rameen Beroukhim, Danny A Milner, Scott R Granter, Jinyan Du,[...]. Nature 2005
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.